Nov 03, 2021

Risk of Age-Related Diseases May Be Higher in Younger B-Cell Non-Hodgkin Lymphoma Survivors than in Their Older Counterparts

Younger B-cell non-Hodgkin lymphoma (B-NHL) survivors had a higher relative risk of developing age-related diseases than older B-NHL survivors five years of more after cancer diagnosis, according to results published in Cancer, Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Nov 11, 2020

Talks with Docs: Tsewang Tashi, Hematologist

Tsewang Tashi., MD, is hematologist and an assistant professor in the division of hematology and hematologic malignancies at the University of Utah. He sees patients at HCI, South Jordan Health Center, and Salt Lake City Veterans Affairs hospital. In this episode of Talks with Docs, he shares with us what lead him to become a physician, what he is most proud of in his work at HCI, and more.

Aug 03, 2020

Kicking Cancer in His Cowboy Boots

Monte Bona was “raised to be a cowboy.” Born in Payson, Utah, he grew up in a small farming community with his parents and five siblings. In 2009 at the age of 71, he was diagnosed with lymphoma. The year 2020 marks more than 11 years since Monte’s diagnosis and treatment. Now in his 80s and after more than a decade of follow-ups, he’s still in the clear.

Apr 16, 2020

A Series of Fortunate Events Lead to Early Cancer Diagnosis

Most nurses don’t do much sitting while they’re on the job. That’s partly why Amy Fenton, internal medicine nurse at University of Utah Hospital, was so excited to sit down one day in mid-April of 2019—for a chair massage, no less. She had no idea that chair massage would lead to an early-stage diagnosis of Hodgkin lymphoma, a time when cancer treatment is typically more effective.

Mar 01, 2020

A pesar de todas las luchas: encontrando esperanza a través del arte

Al desarrollar planes para Huntsman Cancer Institute (HCI por sus siglas en inglés), Jon y Karen Huntsman vieron el arte como pare importante de su visión—“asegurarse de que el ambiente ayudara a sanar tanto como la medicina” HCI es el hogar de una colección con calidad de museo de elementos de alfarería, esculturas y pinturas originales—un total de aproximadamente 2,500 piezas. La importancia de esto se aprecia más sabiendo que la colección completa proviene únicamente de donaciones.

Mar 01, 2020

De la noción al conocimiento: la investigación oncológica salva vidas

Las pruebas clínicas en Huntsman Cancer Institute (HCI por sus siglas en inglés) ayudan a encontrar mejores formas de prevenir, diagnosticar y tratar el cáncer, al poner a prueba la seguridad y efectividad de nuevos fármacos y tratamientos. En promedio, existen 150-200 ensayos clínicos abiertos a pacientes de HCI en cualquier momento dado.

Mar 01, 2020

Despite all the Struggles: Finding Hope through Art

When developing plans for Huntsman Cancer Institute (HCI), Jon and Karen Huntsman saw art as an important part of their vision—“to make sure the environment would be as healing as the medicine.” HCI is home to a museum-quality collection of original paintings, sculpture, and pottery—a total of approximately 2,500 pieces. The significance of this is most appreciated knowing that the entire collection comes solely from donation.

Mar 01, 2020

From Notion to Knowledge: Cancer Research Saves Lives

Clinical trials at Huntsman Cancer Institute (HCI) help find better ways to prevent, diagnose, and treat cancer by testing the safety and effectiveness of new drugs and treatments. On average, there are between 150–200 clinical trials open to HCI patients at any given time.

Sep 17, 2019

Blood Cancer Awareness Month

September is Blood Cancer Awareness month. A diagnosis of blood cancer occurs roughly every 3 minutes in the United States. This type of cancer affects millions of families and individuals.

Mar 01, 2019

Advancing Hematologic Cancer Research and Care

The Center of Excellence in Hematologic Malignancies and Hematology at Huntsman Cancer Institute is a group of more than three dozen doctors and scientists dedicated to hematologic cancers such as leukemia, lymphoma, and multiple myeloma. Integration and collaboration across disciplines will improve clinical care and advance research in these complicated diseases.

Sep 18, 2018

Talks with Docs: Deborah Stephens, DO

Dr. Deborah Stephens cares for patients with lymphoma and chronic lymphocytic leukemia and researches these diseases. In this episode of Talks with Docs, she shares the importance of caring for the whole patient and how becoming a parent has changed her.

May 23, 2018

Huntsman Translational Scholars: Deborah Stephens, DO

HCI established the Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Deborah Stephens, DO, was recently honored with a Huntsman Translational Scholar award. She is the physician leader of Hematology Clinical Trials at Huntsman Cancer Institute and is also an assistant professor in the Division of Hematology and Hematologic Malignancies at the University of Utah.

May 10, 2018

Huntsman Cancer Institute First Adult Cancer Hospital in Mountain West to Offer CAR T Cell Therapy to Patients

Huntsman Cancer Institute announced today that it has been certified to offer both chimeric antigen receptor (CAR) T cell therapies recently approved by the U.S. Food and Drug Administration. The therapies are approved for types of aggressive blood cancers, including B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma. HCI is one of a few locations nationwide, and the only in the Mountain West, approved to offer these new therapies to adult cancer patients.

Feb 15, 2018

Navigating Cancer at a Young Age

For many of young people, a cancer diagnosis is their first real medical issue. This was the case for Marina Pimentel, who was diagnosed with Hodgkin lymphoma, a type of blood cancer, at age 26. Marina worked with an AYA patient navigator to help her manage the complexities of cancer treatment and care.

Feb 01, 2018

Photopheresis: Using Light to Alter the Immune System

Photopheresis treatment seems to modulate the immune system, not suppress it, allowing the body to manage graft-versus-host disease without counteracting the effects of the hematopoietic stem cell transplant.

Aug 09, 2017

Talks with Docs: John Sweetenham, MD

John Sweetenham, MD, shares his experience of growing up in England, what other profession he might have liked to practice, and more.